Co-Diagnostics ( (CODX) ) has released its Q3 earnings. Here is a breakdown of the information Co-Diagnostics presented to its investors.

Tired of paying for Adobe Illustrator's monthly subscription fees? Here are eight alternatives for anyone who needs vector ...

A recent report warns that if Canadian businesses don't accelerate generative AI adoption, they risk falling behind. Will the ...

Japan Tobacco Inc.'s YTD gains are unsurprising, given its muted profit outlook and high market multiples. Explore more ...

The Defense Department is actively working on plans to build cybersecurity requirements for the defense industrial base into defense ...

Inc. is a clinical-stage biotechnology company, which engages in the development of first-in-class gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform ...

Zalando's Q3 GMV rose 7.8 percent to 3.5 billion euros, revenue increased 5 percent to 2.4 billion euros and adjusted EBIT ...

Adeno-associated viral vectors (AAV) have emerged as key players in this growth trajectory, projected to capture a ...

Welcome to the Trade Desk third quarter 2024 earnings conference call. At this time, all participants are in a listen-only ...

A board committee opened an investigation into the brokerage’s workplace after allegations of sexual misconduct by two former ...

Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, ...

Xometry offers a significant growth runway and a well-defined path to non-GAAP profitability and free cash flow generation.